Evaluation of the HeartLogic Diagnostic in Optimizing Guideline-directed Medical Therapy in Patients With Congestive Heart Failure and Chronically Low Ejection Fractions (EFs)
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 135 participants.
Also called NCT07412626
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose supportive care
- Phase
- Not applicable
- Enrolled
- 135 participants
- Sponsor
- Registry
-
NCT07412626
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07412626. Randomized; no masking; primary purpose supportive care. Start 2026-04-01 (anticipated); primary completion 2027-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of the HeartLogic Diagnostic in Optimizing Guideline-directed Medical Therapy in Patients With Congestive Heart Failure and Chronically Low Ejection Fractions (EFs)
- Acronym
- Heartlogic ISR
- Condition
- Congestive Heart Failure Chronic
- Condition
- Low Ejection Fraction
- Intervention (Device)
- Heartlogic Diagnostic Tool Threshold Change
- Intervention (Device)
- Heartlogic Diagnostic Tool Unchanged Threshold
- Lead sponsor
- Robert Pickett
- Collaborator
- Boston Scientific Corporation
- Collaborator
- Ascension Health
Record details
- Record id
cardio:ct-nct07412626- Content hash
db7468263d17a8757c1d110354dac11978565a8f98579fad8b3c7feea96779b0